GSK-3β/β-catenin cascades have been reported that play a crucial role in the onset of depressive symptoms in animal models and thus have become a target of interest for depressive symptom alleviation and elucidation of the pathogenesis of depression [10–14]. This evidence concerns the gene GSK3B and major depressive disorder.